A detailed history of Dcf Advisers, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Dcf Advisers, LLC holds 3,000 shares of JNJ stock, worth $498,450. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,000
Previous 1,500 100.0%
Holding current value
$498,450
Previous $237,000 84.81%
% of portfolio
0.24%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $216,570 - $236,670
1,500 Added 100.0%
3,000 $438,000
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $718,474 - $804,876
-4,613 Reduced 75.46%
1,500 $233,000
Q2 2023

Aug 09, 2023

BUY
$154.35 - $166.11 $943,541 - $1.02 Million
6,113 New
6,113 $1.01 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $807,500 - $897,350
-5,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $685,550 - $786,900
5,000 New
5,000 $787,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Dcf Advisers, LLC Portfolio

Follow Dcf Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.